Serhat Çelik

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

B. Ferhanoğlu, L. Kaynar, M. Yenerel, 2022, Annals of Hematology.

P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

B. Ferhanoğlu, L. Kaynar, M. Yenerel, 2022, Annals of hematology.

Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

G. Zararsiz, M. Çetin, K. Deniz, 2023, Annals of Hematology.

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

B. Ferhanoğlu, L. Kaynar, M. Yenerel, 2022, Annals of Hematology.

Donor cell leukemia after allogeneic hematopoietic stem cell transplantation: a case report

L. Kaynar, H. Akalın, Z. Güven, 2023, Journal of Current Hematology & Oncology Research.

The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study.

L. Kaynar, Z. Güven, M. Keklik, 2023, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.